Business Description
Biote Corp
NAICS : 621999
SIC : 8099
ISIN : US0906831039
Description
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.31 | |||||
| Equity-to-Asset | -1.29 | |||||
| Debt-to-Equity | -0.94 | |||||
| Debt-to-EBITDA | 4.92 | |||||
| Interest Coverage | 3.69 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.69 | |||||
| Beneish M-Score | -3.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -22.3 | |||||
| 3-Year EBITDA Growth Rate | -56.4 | |||||
| 3-Year EPS without NRI Growth Rate | -40.3 | |||||
| 3-Year FCF Growth Rate | -34.2 | |||||
| 3-Year Book Growth Rate | 27.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 13.66 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.33 | |||||
| 9-Day RSI | 58.36 | |||||
| 14-Day RSI | 58.33 | |||||
| 3-1 Month Momentum % | -3.69 | |||||
| 6-1 Month Momentum % | -7.56 | |||||
| 12-1 Month Momentum % | 5.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 104.41 | |||||
| Days Sales Outstanding | 15.58 | |||||
| Days Payable | 30.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -65.4 | |||||
| Shareholder Yield % | 2.7 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.05 | |||||
| Operating Margin % | 17.79 | |||||
| Net Margin % | 5.2 | |||||
| FCF Margin % | 17.07 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 7.62 | |||||
| ROIC % | 38.65 | |||||
| 3-Year ROIIC % | 1343.23 | |||||
| ROC (Joel Greenblatt) % | 139.75 | |||||
| ROCE % | 21.09 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.15 | |||||
| Forward PE Ratio | 12.19 | |||||
| PE Ratio without NRI | 11.55 | |||||
| PS Ratio | 1.17 | |||||
| Price-to-Free-Cash-Flow | 6.67 | |||||
| Price-to-Operating-Cash-Flow | 5.52 | |||||
| EV-to-EBIT | 13.96 | |||||
| EV-to-Forward-EBIT | 1.44 | |||||
| EV-to-EBITDA | 11.74 | |||||
| EV-to-Forward-EBITDA | 4.15 | |||||
| EV-to-Revenue | 1.52 | |||||
| EV-to-Forward-Revenue | 1.34 | |||||
| EV-to-FCF | 8.85 | |||||
| Earnings Yield (Greenblatt) % | 7.16 | |||||
| FCF Yield % | 16.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BTMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biote Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 193.06 | ||
| EPS (TTM) ($) | 0.26 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 78.95 | ||
| 14-Day RSI | 58.33 | ||
| 14-Day ATR ($) | 0.339594 | ||
| 20-Day SMA ($) | 6.426 | ||
| 12-1 Month Momentum % | 5.7 | ||
| 52-Week Range ($) | 3.6538 - 8.44 | ||
| Shares Outstanding (Mil) | 31.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biote Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biote Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biote Corp Frequently Asked Questions
What is Biote Corp(BTMD)'s stock price today?
The current price of BTMD is $6.54. The 52 week high of BTMD is $8.44 and 52 week low is $3.65.
When is next earnings date of Biote Corp(BTMD)?
The next earnings date of Biote Corp(BTMD) is 2025-03-12 Est..
Does Biote Corp(BTMD) pay dividends? If so, how much?
Biote Corp(BTMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers